Dean Campbell
Company: CrownBio
Job title: Director – Scientific Engagement
Seminars:
Discussion/Q&A 12:00 pm
day: Day One
Patient-Derived Experimental Models for Translational Cancer Research 11:30 am
Patient-derived organoids (PDO) and Patient-derived xenografts (PDX) are patient-relevant platforms for efficacy evaluation of cancer therapeutics PDX-derived organoids (PDXO) is a new in vitro platform featuring both patient relevance and scalability Leveraging our extensive PDX collection to run surrogate clinical trials in a preclinical settingRead more
day: Day One